1978
DOI: 10.1016/0091-6749(78)90160-4
|View full text |Cite
|
Sign up to set email alerts
|

Polymerized whole ragweed: An improved method of immunotherapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
6
0

Year Published

1979
1979
2010
2010

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 37 publications
(6 citation statements)
references
References 10 publications
0
6
0
Order By: Relevance
“…While several clinical studies on the effect of im munotherapy with modified grass or ragweed aller gens have already been published [2,5,7,11,25], only limited experimental data [12,26,28] are available concerning chemically modified insect venoms. Sting ing insect hypersensitivity is an important indication for immunotherapy and side effects during treatment with the available venom preparations may represent a significant problem [6,24], The purpose of this study is to analyze different chemical modifications of honeybee venom (BV) with regard to their potential use for the immunotherapy of patients allergic to honeybee stings.…”
Section: Introductionmentioning
confidence: 99%
“…While several clinical studies on the effect of im munotherapy with modified grass or ragweed aller gens have already been published [2,5,7,11,25], only limited experimental data [12,26,28] are available concerning chemically modified insect venoms. Sting ing insect hypersensitivity is an important indication for immunotherapy and side effects during treatment with the available venom preparations may represent a significant problem [6,24], The purpose of this study is to analyze different chemical modifications of honeybee venom (BV) with regard to their potential use for the immunotherapy of patients allergic to honeybee stings.…”
Section: Introductionmentioning
confidence: 99%
“…The above peculiarity of KCNO-treated allergens allows the possibility to distinguish monomeric from polymeric allergoids such as those obtained by the reaction of allergens with glutaraldehyde [19, 20]. Polymeric allergoids are characterized by a significant increase in the molecular size of their components (reaching more than 1,000 kDa) as result of inter-/intramolecular cross-linking.…”
Section: Discussionmentioning
confidence: 99%
“…Such allergoids are characterized by a significant reduction in allergenic potency (probably as the result of an alteration in IgE epitopes of allergenic molecules) while still maintaining their immunogenic properties (capacity to induce IgG antibodies able to interact with native extract). Furthermore, unlike polymeric allergoids (such as those obtained by reaction with aldehydes) which are characterized by a strong increase in molecular dimension of their components due to inter-/intramolecular cross-linking phenomena [19, 20], they maintain a native molecular (monomeric) dimension of their own components [18]. …”
Section: Introductionmentioning
confidence: 99%
“…Although the use of GA-modified protein antigens for immuno therapy of human allergic disorders has considerably expanded in recent years, most previous studies in both humans [12][13][14][15] and animal models [16][17][18] have been carried out with preparations likely to display a high degree of molecular heterogeneity.…”
Section: Discussionmentioning
confidence: 99%